<
new post
StocksRunner logo
mail
search
 
menu
 
Biogen
$192.03
-0.03%
 
  Set Alerts  
  
  Overview  
  
  Comments  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Headlines  
 

BIIB Stock Analysis & IQ Rating | Biogen

 
 

BIIB

 

Biogen

$192.03

 
-$0.05 | -0.03%
 
Set Alerts
 
  Overview  
  
  Comments  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Headlines  
 
 
52W High
$202.41
 
 
MKT CAP
$28.08B
 
52W Low
$110.04
 
 
VOL
$795.11K
 
P/E Ratio
21.85
 
 
AVG VOL
$1.61M
 
RSI
57.90
 
 
TREND
Uptrend
 
 
 

BIIB Stock IQ

 
lock  Login to see Biogen (BIIB) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 
 

BIIB Target Price

 
 
 

Strengths

 
 

BIIB Rewards

 Trading below its fair value

 
 

BIIB Price Performance

 
 

$173.12   (+10.92%)

$181.96   (+5.53%)

$138.52   (+38.63%)

$150.71   (+27.42%)

 
 
1year
6month
3month
1month

BIIB Analysts Opinion

Overall standing based on market and analyst consensus. menu Hover over the category for more information

Earnings

×

Earnings

BIIB Earnings Sentiment Above analyst estimates
BIIB Earnings Sentiment Earnings decline YoY

Rating

×

Rating

Momentum

×

Momentum

BIIB Momentum Analysis Has been gaining momentum

Activity

×

Activity

Future

×

Future

BIIB Future Sentiment Trading below its fair value
BIIB Analysts Opinion

BIIB Analysts opinion is positive but there was a setback from the past 3 months

BIIB Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

73%
Consensus Rating
0%
Buy
Opinion
20%
Trend
Score
100%
Potential
Score
BIIB Street Sentiment

BIIB Street Sentiment is bullish and have positive views on the near-term outlook

BIIB Risk Level

BIIB has Low risk level

BIIB Risk Level
Low
LOW
HIGH

BIIB Performance Sentiment

Sentiments overview associated with events and the stock performance

73%
Positive
11 out of 15
events present
13%
Negative
2 out of 15
events present
Very Bullish
Bullish
Neutral
Bearish
Very Bearish

Key Price Levels

Average key support and resistance price levels

Support Price
$171.59
Resistance Price
$201.18
Current Price Range
$192.03
$171.59
$201.18
Show methods +
 
 

Analyst Consensus

 

Recent Upgrades and Downgrades

 
 
67%
Consensus Rating
BUY
4
Buy
2
Hold
0
Sell
Date
Action
Rating
Firm

Nov 22, 2025

 

Reiterate

 

Neutral

 

Piper Sandler

 

Nov 07, 2025

 

Upgrade

 

Buy

 

Stifel

 

Nov 01, 2025

 

Reiterate

 

Outperform

 

RBC

 

Sep 25, 2025

 

Initiate

 

Buy

 

Jefferies

 

Sep 25, 2025

 

Upgrade

 

Neutral

 

Goldman Sachs

 
 
 
BIIB Latest Analysis +
 
 
FAQ About BIIB Stock Insights
 

What is BIIB current stock price?

What are BIIB stock strengths?

What is BIIB Risk Level?

What is BIIB market cap and volume?

What is BIIB current Stock IQ?

Should I buy BIIB stock right now?

Is BIIB a Strong Buy right now?

What does a 'Strong Buy' rating mean for BIIB?

What does a 'Strong Sell' rating mean for BIIB?

What factors influence BIIB's Stock IQ?

 
 
StocksRunner

Explore our BIIB Stock insights

  • In-Depth Market Analysis and Trends
  • Expert Insights on Market Dynamics
  • Tailored BIIB Stock Strategies
  • Effective Risk Management
 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our BIIB Daily Alerts

Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

 
Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

 
Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

 
Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

 
About StocksRunner

Log In

Sign Up

Plans & Pricing

Contact Us

Terms of use

Privacy Policy

 
 
 
 

BIIB

 

Biogen

 
Set Alerts
 
 

Current Price

 

$192.03

 
-$0.05 | -0.03%
 
 
52W High
$202.41
 
 
MKT CAP
$28.08B
 
52W Low
$110.04
 
 
VOL
$795.11K
 
P/E Ratio
21.85
 
 
AVG VOL
$1.61M
 
RSI
57.90
 
 
TREND
Uptrend
 
 
 
  Overview  
  
  Comments  
  
  Insights  
  
   Risks   
  
  Rating  
  
  Chart  
  
  Analysts  
  
  Street  
  
  Sentiment  
 
 
 

Runners Also Watch

 
 
 
Symbol
Close
Change
 

AMGN

Amgen

374.75

-0.20%

 

CHRS

Coherus BioSciences

1.63

-4.68%

 

ALVO

Alvotech

4.14

-4.17%

 
 
 
 
 
user
 
 
 
 

BIIB Price Performance

 
 

$173.12   (+10.92%)

$181.96   (+5.53%)

$138.52   (+38.63%)

$150.71   (+27.42%)

 
 
1year
6month
3month
1month
 

BIIB Analysts Opinion

Overall standing per market and analyst expectations. menu Hover over the category for more information

Earnings

×

Earnings

BIIB Earnings Sentiment Above analyst estimates
BIIB Earnings Sentiment Earnings decline YoY

Rating

×

Rating

Momentum

×

Momentum

BIIB Momentum Sentiment Has been gaining momentum

Activity

×

Activity

Future

×

Future

BIIB Future Sentiment Trading below its fair value
BIIB Analysts Opinion

BIIB Analysts opinion is positive but there was a setback from the past 3 months

BIIB Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

73%
Consensus Rating
0%
Buy
Opinion
20%
Trend
Score
100%
Potential
Score
BIIB Street Sentiment

BIIB Street Sentiment is bullish and have positive views on the near-term outlook

BIIB Risk Level

BIIB has Low risk level

BIIB Risk Level
Low
LOW
HIGH
BIIB Performance Sentiment
Sentiments overview associated with events and the stock performance.
73%
Positive
11 out of 15
events present
13%
Negative
2 out of 15
events present
Very Bullish
Bullish
Neutral
Bearish
Very Bearish

Key Price Levels

Average key support and resistance price levels

Support Price
$171.59
Resistance Price
$201.18
Current Price Range
$192.03
$171.59
$201.18
Show methods +

Latest Analyst Actions

Overall Wall Street Rating

67%
Consensus Rating
BUY
4
Buy
2
Hold
0
Sell
Date
Action
Rating
Firm
Nov 22, 2025
Reiterate
Neutral
Piper Sandler
Nov 07, 2025
Upgrade
Buy
Stifel
Nov 01, 2025
Reiterate
Outperform
RBC
Sep 25, 2025
Initiate
Buy
Jefferies
Sep 25, 2025
Upgrade
Neutral
Goldman Sachs
 
 
 
 

BIIB Stock IQ

 
 
 
lock  Login to unlock Biogen (BIIB) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 
 
 

Target Price

 
 
 
 
 
 
 

Stock Insights

 
 
 
 

Strengths

 
 

BIIB Rewards

 Trading below its fair value

 
 
 

BIIB Latest Analysis

 
 
 

Why Biogen Inc. (BIIB) is a Top Value Stock for the Long-Term. The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Heres why you should take advantage.

 

Thu Feb 19, 2026

$192.08 | -1.06%
 
Potential

Biogen Inc. (BIIB) Presents at Piper Sandler Virtual Novel Targets in Immunology Symposium Transcript.

 

Fri Feb 13, 2026

$196.52 | +0.52%
 
Activity

Wedbush Lifts PT on Biogen Inc. (BIIB) to $187 From $178 – Heres Why. Biogen Inc. (NASDAQ:BIIB) is one of the best medical research stocks to buy according to hedge funds. On February 10 Wedbush lifted the price target on Biogen Inc. (NASDAQ:BIIB) to $187 from $178 maintaining a Neutral rating on the shares. The firm told investors that Biogen Inc. (NASDAQ:BIIB) delivered another  top-/bottom-line beat in its fiscal Q4 [….]

 

Fri Feb 13, 2026

$196.52 | +0.52%
 
Potential
Rating

Biogen Announces Board Chair Transition. Caroline Dorsa to retire from the Biogen Board of Directors. Dr. Maria C. Freire Director since 2021 elected as new Chair

 

Wed Feb 11, 2026

$191.20 | +1.17%
 
Activity

Biogen Inc. (BIIB) Q4 Earnings and Revenues Top Estimates. Biogen (BIIB) delivered earnings and revenue surprises of 23.40% and 3.06% respectively for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

 

Fri Feb 6, 2026

$201.18 | +8.53%
 
Earnings

Biogen Q4 Results Top Estimates. Guides FY26 Adj. EPS Above Estimates . (RTTNews) - Biotechnology company Biogen Inc. (BIIB) reported Friday a net loss attributable to the company for the fourth quarter of $48.9 million or $0.33 per share compared to net income of $266.8 million or $1.83 per share in the prior-year quarter.

 

Fri Feb 6, 2026

$201.18 | +8.53%
 
Earnings
 
 
 
 
 
StocksRunner

Discover BIIB Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of BIIB. We're here to help you make informed investment decisions today.

 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our BIIB Daily Alerts

Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

BIIB Stock trends

BIIB Stock performance

BIIB Stock analysis

BIIB investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner logo
 

BIIB Alerts

Real-time signals powered by data
×

Price-Based

Triggers when the stock breaks through a known resistance level
 
Triggers when the stock drops below a key support level
 
Notifies if the stock moves up/down by a set percentage (e.g. ±5%)
 
Alerts when the stock hits a new high or low
 
Signals proximity to long-term highs or lows (e.g. within 5%)
 

Technical Indicator (Pro Plan)

Volume spikes 2x–3x above average. Indicates strong buying/selling pressure
 
Tracks large intraday swings, signaling potential opportunities or risk
 
Signals potential trend reversals or continuations
 
Long-term bullish/bearish trend signals from MA crossovers
 
RSI above 70 or below 30 to identify possible reversals
 
Signals momentum shifts
 

Fundamental Indicator (Master Plan)

Upcoming or just-released earnings reports
 
Alerts after results compared to expectations
 
Changes in rating or target price
 
New or changed dividends
 
Large trades by company insiders
 
M&A, lawsuits, product launches, etc
 
High volume/open interest in call/put contracts
 
Surge in mentions or sentiment shifts
 
 
Cancel
 
×
 
0/666
joker
 
Post
 
✕
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing BIIB

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

 
✕
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing BIIB

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.